Código QR (código de barras bidimensional)

Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysisResearch in context

Summary: Background: TP53 mutation is a critical predictor of early disease progression and poor prognosis in mantle cell lymphoma (MCL). Optimal treatment for these patients remains unclear. This systematic review and meta-analysis evaluated various strategies for achieving remission in TP53-mutat...

ver descrição completa

Na minha lista:
Principais autores: Na Zhang, Jiegang Xu, Chengxin Luo, Rushuang Xu, Yan Zeng, Dongfeng Zeng, Shuangnian Xu, Xi Li
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2025-07-01
coleção:EClinicalMedicine
Assuntos:
Mantle cell lymphoma
TP53 mutations
Remission strategies
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2589537025002688
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados